Warning: mail() has been disabled for security reasons in /home/markrref/public_html/usmarketbuzz.com/wp-content/mu-plugins/bps-mu-tools.php on line 110

Warning: Cannot modify header information - headers already sent by (output started at /home/markrref/public_html/usmarketbuzz.com/wp-content/mu-plugins/bps-mu-tools.php:110) in /home/markrref/public_html/usmarketbuzz.com/wp-content/plugins/bigcontact/BigContact.php on line 43

Warning: Cannot modify header information - headers already sent by (output started at /home/markrref/public_html/usmarketbuzz.com/wp-content/mu-plugins/bps-mu-tools.php:110) in /home/markrref/public_html/usmarketbuzz.com/wp-includes/feed-rss2.php on line 8
Inc.(NYSE:NPO) – US Market Buzz http://www.usmarketbuzz.com Nation and Economy Mon, 20 Jul 2020 16:28:22 +0000 en-US hourly 1 https://wordpress.org/?v=4.9.23 Stocks Gainers: Rosetta Genomics Ltd. (USA)(NASDAQ:ROSG), EnPro Industries, Inc.(NYSE:NPO), Alnylam Pharmaceuticals, Inc.(NASDAQ:ALNY), BEAM Inc(NYSE:BEAM) http://www.usmarketbuzz.com/rosg-stocks-gainers-rosetta-genomics-ltd-usanasdaqrosg-enpro-industries-inc-nysenpo-alnylam-pharmaceuticals-inc-nasdaqalny-beam-incnysebeam-1405 Mon, 13 Jan 2014 15:00:18 +0000 http://www.usmarketbuzz.com/?p=1405 Rosetta Genomics Ltd. (USA)(NASDAQ:ROSG) shares climbed 24.76% to $3.98. Rosetta Genomics Ltd., is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. In July 2011, the Company launched its fifth product – miRview lung.

Free Urgent Insider Catalyst Report For ROSG Available Here

EnPro Industries, Inc.(NYSE:NPO) shares gained 33.42% to $79.00. Enpro Industries, Inc. (Enpro), is engaged in the designing, development, manufacturing, and marketing of engineered industrial products. As of December 31, 2012, the Company had 61 primary manufacturing facilities located in 12 countries, including the United States. The Company operates in three segments: Sealing Products segment, Engineered Products segment and Engine Products and Services segment.

Free Urgent Insider Catalyst Report For NPO Available Here

Alnylam Pharmaceuticals, Inc.(NASDAQ:ALNY) shares added 28.20% to $84.88. Alnylam Pharmaceuticals, Inc. (Alnylam) is a biopharmaceutical company developing therapeutics based on ribonucleic acid interface (RNAi). Its Alnylam 5×15, is focused on the development and commercialization of novel RNAi therapeutics for the treatment of genetically defined diseases. Its core programs in clinical or pre-clinical development are: ALN-TTR for the treatment of transthyretin-mediated amyloidosis (ATTR); ALN-APC for the treatment of hemophilia; ALN-PCS for the treatment of severe hypercholesterolemia; ALN-HPN for the treatment of refractory anemia, and ALN-TMP for the treatment of hemoglobinopathies, including beta-thalassemia and sickle cell anemia.

Free Urgent Insider Catalyst Report For ALNY Available Here 

BEAM Inc(NYSE:BEAM) shares gained 24.68% to $83.50. Beam Inc. (Beam) is a premium spirits company that makes and sells branded distilled spirits products in markets worldwide. The Company’s principal products include bourbon whiskey, tequila, Scotch whisky, Canadian whisky, vodka, cognac, rum, cordials, and ready-to-drink pre-mixed cocktails. Beam’s portfolio consists of brands it identifies as Power Brands, Rising Stars, Local Jewels and values Creators.

Free Urgent Insider Catalyst Report For BEAM Available Here

 

]]>